Amneal Pharmaceuticals Inc (NQ: AMRX )

6.760 -0.120 (-1.74%)

Streaming Delayed Price Updated: 11:50 AM EDT, Aug 7, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	285,232
Open	6.920
Bid (Size)	6.750 (2)
Ask (Size)	6.760 (4)
Prev. Close	6.880
Today's Range	6.740 - 6.970
52wk Range	5.010 - 7.735
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

July 29, 2024

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal to Report Second Quarter 2024 Results on August 9, 2024

July 11, 2024

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Performance

YTD	+13.04%	+13.04%
1 Month	-0.88%	-0.88%
3 Month	+3.84%	+3.84%
6 Month	+20.71%	+20.71%
1 Year	+8.86%	+8.86%

More News

Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant

July 09, 2024

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)

July 01, 2024

From Kashiv BioSciences, LLC

Via Business Wire

Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar

July 01, 2024

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Releases 2023 Environmental, Social and Governance Report

June 28, 2024

From Amneal Pharmaceuticals, Inc.

Via Business Wire

3 Stocks to Buy That Are Up 100% Over the Past 52 Weeks

June 25, 2024

Via InvestorPlace

Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies

June 05, 2024

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.